21.5 C
New York
Monday, June 17, 2024
HomeMarkets
Markets

8 Biggest Price Target Changes For Monday

By Insider Scoop
0
41
psw-placeholder
psw-placeholder

Courtesy of Benzinga.

  • Credit Suisse lowered the price target on Bristol-Myers Squibb Co (NYSE: BMY) from $86 to $63. Bristol-Myers Squibb shares closed at $63.28 on Friday.
  • Jefferies boosted the price target for NVIDIA Corporation (NASDAQ: NVDA) from $56 to $69. NVIDIA shares closed at $58.20 on Friday.
  • Goldman Sachs boosted the price target for BlackRock, Inc. (NYSE: BLK) from $390 to $400. BlackRock shares closed at $374.75 on Friday.
  • Cantor Fitzgerald raised the price target on TrovaGene Inc (NASDAQ: TROV) from $5 to $7. TrovaGene shares closed at $5.20 on Friday.
  • Citi increased Raptor Pharmaceutical Corp. (NASDAQ: RPTP) price target from $6 to $8. Raptor Pharmaceutical shares closed at $6.89 on Friday.
  • CLSA increased Reynolds American, Inc. (NYSE: RAI) price target from $52 to $54. Reynolds American shares closed at $48.92 on Friday.
  • UBS raised Ferrari N.V. (NYSE: RACE) price target from $50 to $53. Ferrari shares closed at $46.88 on Friday.
  • Credit Suisse raised the price target for Merck & Co., Inc. (NYSE: MRK) from $62 to $73. Merck shares closed at $63.86 on Friday.

Latest Ratings for TROV

Date Firm Action From To
Aug 2016 Cantor Fitzgerald Upgrades Hold Buy
Apr 2016 Leerink Swann Downgrades Outperform Sector Perform
Apr 2016 Cantor Fitzgerald Downgrades Buy Hold

View More Analyst Ratings for TROV


View the Latest Analyst Ratings

Posted-In: Price Target ChangesPrice Target Analyst Ratings

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,081FansLike
396,312FollowersFollow
2,300SubscribersSubscribe

Latest Articles

Load more

Note: The material presented in this commentary is provided for informational purposes only and is based upon information that is considered to be reliable. However, neither PSW Investments, LLC d/b/a PhilStockWorld (PSW) nor its affiliates warrant its completeness, accuracy or adequacy and it should not be relied upon as such. Neither PSW nor its affiliates are responsible for any errors or omissions or for results obtained from the use of this information. Past performance, including the tracking of virtual trades and portfolios for educational purposes, is not necessarily indicative of future results. Neither Phil, Optrader, or anyone related to PSW is a registered financial adviser and they may hold positions in the stocks mentioned, which may change at any time without notice. Do not buy or sell based on anything that is written here, the risk of loss in trading is great.

This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities or other financial instruments mentioned in this material are not suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only intended at the moment of their issue as conditions quickly change. The information contained herein does not constitute advice on the tax consequences of making any particular investment decision. This material does not take into account your particular investment objectives, financial situations or needs and is not intended as a recommendation to you of any particular securities, financial instruments or strategies. Before investing, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.

Contact us: support@philstockworld.com

© Copyright - PSW, LLC.

2024
0
Would love your thoughts, please comment.x
()
x